Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,857 | -110,090 | -94,100 | -7,012 | -5,476 |
| Depreciation Amortization | 74 | 74,261 | 74,189 | 4 | 2 |
| Accounts receivable | -2,708 | 14,149 | 14,149 | 14,149 | 14,029 |
| Accounts payable and accrued liabilities | N/A | 8,290 | N/A | N/A | N/A |
| Other Working Capital | -7,537 | 12,245 | 10,257 | 15,173 | 14,568 |
| Other Operating Activity | 4,613 | -21,278 | -14,490 | -14,936 | -12,560 |
| Operating Cash Flow | $-19,415 | $-22,423 | $-9,995 | $7,378 | $10,563 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -46 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 29,700 | 29,700 | -157 | N/A |
| Other Investing Activity | 0 | -4,501 | -4,501 | 0 | 0 |
| Investing Cash Flow | $-23 | $25,153 | $25,199 | $-157 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 298 | 155,833 | 155,745 | N/A | N/A |
| Dividend Paid | N/A | -4,412 | -4,412 | N/A | N/A |
| Other Financing Activity | 0 | -9,617 | -9,617 | -1 | 0 |
| Financing Cash Flow | $298 | $141,804 | $141,716 | $-1 | $N/A |
| Beginning Cash Position | 148,989 | 4,455 | 4,455 | 4,455 | 4,455 |
| End Cash Position | 129,849 | 148,989 | 161,375 | 11,675 | 15,018 |
| Net Cash Flow | $-19,140 | $144,534 | $156,920 | $7,220 | $10,563 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,415 | -22,423 | -9,995 | 7,378 | 10,563 |
| Capital Expenditure | -23 | -46 | N/A | N/A | N/A |
| Free Cash Flow | -19,438 | -22,469 | -9,995 | 7,378 | 10,563 |